Skip to content
AiONAiON
Medical directoryActive ingredient

Veoza

The brand name in Spain and the European Union for fezolinetant, 45 mg film-coated tablets from Astellas Pharma Europe B.V. Authorised by the European Commission on 7 December 2023, available on prescription and subject to additional monitoring (black triangle).

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.